Adverse event totals18

The totals the trial posted for each group.

1 to 18 of 18

Total	Group	Affected	At risk
Total, all-cause mortality	Placebo	0	82
Total, all-cause mortality	Aprocitentan 5 mg	0	82
Total, all-cause mortality	Aprocitentan 10 mg	0	82
Total, all-cause mortality	Aprocitentan 25 mg	0	82
Total, all-cause mortality	Aprocitentan 50 mg	0	81
Total, all-cause mortality	Lisinopril 20 mg	0	81
Total, other adverse events	Placebo	30	82
Total, other adverse events	Aprocitentan 5 mg	18	82
Total, other adverse events	Aprocitentan 10 mg	24	82
Total, other adverse events	Aprocitentan 25 mg	32	82
Total, other adverse events	Aprocitentan 50 mg	22	81
Total, other adverse events	Lisinopril 20 mg	25	81
Total, serious adverse events	Placebo	0	82
Total, serious adverse events	Aprocitentan 5 mg	0	82
Total, serious adverse events	Aprocitentan 10 mg	0	82
Total, serious adverse events	Aprocitentan 25 mg	2	82
Total, serious adverse events	Aprocitentan 50 mg	0	81
Total, serious adverse events	Lisinopril 20 mg	1	81

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02603809/event-totals